Pharmacokinetic and pharmacodynamic drug interactions between digoxin and macrogol 4000, a laxative polymer, in healthy volunteers

被引:15
|
作者
Ragueneau, I
Poirier, JM
Radembino, N
Sao, AB
Funck-Brentano, C
Jaillon, P
机构
[1] St Antoine Univ Hosp, Clin Pharmacol Unit, F-75012 Paris, France
[2] St Antoine Univ Hosp, Dept Pharmacol, F-75012 Paris, France
关键词
digoxin; drug interaction; healthy volunteers; macrogol; 4000; pharmacodynamics; pharmacokinetics;
D O I
10.1046/j.1365-2125.1999.00025.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aims The aim of this study was to examine the bioequivalence between a single oral dose of digoxin administered alone and with a coadministration of macrogol 4000 (a laxative polymer) in 18 healthy volunteers. Methods This was an open, randomised, two-way cross-over study, with a single dose oral administration of 0.5 mg digoxin administered alone or in combination with macrogol 4000, 20 g day(-1) during 8 days. Pharmacokinetics of digoxin, heart rate and PR ECG interval at rest were assessed. Results Macrogol 4000 coadministration was associated with a 30% decrease of digoxin AUC and a 40% decrease in its C-max (P<0.05). Digoxin t(max) and t(1/2,z) were nor significantly altered. Heart rate and PR interval did not differ during the two therapeutic sequences, digoxin alone and digoxin in combination. Conclusions Macrogol 4000 coadministration interacts with single-dose digoxin pharmacokinetics. This is most likely due to a reduction of the intestinal absorption of digoxin. However, there was no consequence of this interaction on heart rate and AV conduction.
引用
收藏
页码:453 / 456
页数:4
相关论文
共 50 条
  • [21] Pharmacokinetic and pharmacodynamic interaction trial after repeated oral doses of imidapril and digoxin in healthy volunteers
    Harder, S
    Thurmann, PA
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 43 (05) : 475 - 480
  • [22] Development of a sequential linked pharmacokinetic and pharmacodynamic simulation model for ivabradine in healthy volunteers
    Duffull, SB
    Aarons, L
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 10 (04) : 275 - 284
  • [23] Effect of Food on the Pharmacokinetic and Pharmacodynamic Profiles of Hetrombopag in Healthy Volunteers
    Wang, Zhenlei
    Chen, Xiaogang
    Li, Aiwei
    Chen, Li
    Wang, Yongsheng
    Zheng, Li
    CLINICAL THERAPEUTICS, 2020, 42 (12) : 2280 - 2288
  • [24] Investigation of Pharmacodynamic and Pharmacokinetic Interactions Between Rivaroxaban and Enoxaparin in Healthy Male Subjects
    Kubitza, Dagmar
    Becka, Michael
    Schwers, Stephan
    Voith, Barbara
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2013, 2 (03): : 270 - 277
  • [25] Evaluation of the pharmacokinetic interaction after multiple oral doses of linagliptin and digoxin in healthy volunteers
    C. Friedrich
    A. Ring
    T. Brand
    R. Sennewald
    E. U. Graefe-Mody
    H.-J. Woerle
    European Journal of Drug Metabolism and Pharmacokinetics, 2011, 36 : 17 - 24
  • [26] In Vitro P-Glycoprotein Interactions and Steady-State Pharmacokinetic Interactions Between Tolvaptan and Digoxin in Healthy Subjects
    Shoaf, Susan E.
    Ohzone, Yoshihiro
    Ninomiya, Shin-ichi
    Furukawa, Masayuki
    Bricmont, Patricia
    Kashiyama, Eiji
    Mallikaarjun, Suresh
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (05) : 761 - 769
  • [27] Oesophageal bezoar: Is there a drug interaction between enteral nutrition and macrogol laxative?
    Viard, D.
    Destere, A.
    Bertrand, B.
    Piquet, E.
    Becuwe, G.
    Merino, D.
    Gerard, A.
    Ewig, E.
    Ben Othman, N.
    Rocher, F.
    Drici, M. D.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 150 - 151
  • [28] Pharmacokinetic Interactions Between Isavuconazole and the Drug Transporter Substrates Atorvastatin, Digoxin, Metformin, and Methotrexate in Healthy Subjects
    Yamazaki, Takao
    Desai, Amit
    Goldwater, Ronald
    Han, David
    Lasseter, Kenneth C.
    Howieson, Corrie
    Akhtar, Shahzad
    Kowalski, Donna
    Lademacher, Christopher
    Rammelsberg, Diane
    Townsend, Robert
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2017, 6 (01): : 66 - 75
  • [29] Pharmacokinetic-Pharmacodynamic Modeling of Candesartan Cilexetil in Healthy Chinese Volunteers
    Huang, Xiao-hui
    Xie, Xue-feng
    Huang, Ji-han
    Chen, Yun
    Li, Jian-chun
    Qiu, Fu-rong
    Xie, Hai-tang
    LATIN AMERICAN JOURNAL OF PHARMACY, 2013, 32 (02): : 239 - 245
  • [30] A Pharmacokinetic Drug Interaction Between Fimasartan and Linagliptin in Healthy Volunteers
    Kang, Woo Youl
    Lee, Hae Won
    Gwon, Mi-Ri
    Cho, Seungil
    Shim, Wang-Seob
    Lee, Kyung-Tae
    Yang, Dong Heon
    Seong, Sook Jin
    Yoon, Young-Ran
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 2101 - 2111